Tuberculosis susceptibility – implications for drug development and therapy

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.4, Iss.9, 2003-09, pp. : 1455-1460

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Discovery of epilepsy susceptibility genes: implications for therapy development and pharmacogenomics

By Ferraro Thomas N

Pharmacogenomics, Vol. 13, Iss. 7, 2012-05 ,pp. : 731-734

Future Medicine

Access to resources Recommend Favorite

Drug Susceptibility Testing for Optimizing Tuberculosis Treatment

Current Pharmaceutical Design, Vol. 17, Iss. 27, 2011-09 ,pp. : 2863-2874

Bentham Science Publishers

Access to resources Recommend Favorite

Inhaled Drug Delivery for Tuberculosis Therapy

By Muttil Pavan Wang Chenchen Hickey Anthony

Pharmaceutical Research, Vol. 26, Iss. 11, 2009-11 ,pp. : 2401-2416

Springer Publishing Company

Access to resources Recommend Favorite

New tuberculosis drug development: targeting the shikimate pathway

By Kapnick Senta M Zhang Ying

Expert Opinion on Drug Discovery, Vol. 3, Iss. 5, 2008-05 ,pp. : 565-577

Informa Healthcare

Access to resources Recommend Favorite

Tuberculosis: Current Treatment and New Drug Development

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 5, Iss. 4, 2006-10 ,pp. : 331-344

Bentham Science Publishers

Access to resources Recommend Favorite